JGC
BSX icon

J. Goldman & Co’s Boston Scientific BSX Stock Holding History

J. Goldman & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Sell
10,000
-122,500
-92% -$6.65M 0.01% 569
2026
Q1 		$8.31M Buy
+132,500
New +$10.6M 0.24% 124
2024
Q1 		– Sell
-87,500
Closed -$5.06M – 424
2023
Q4 		$5.06M Buy
+87,500
New +$4.67M 0.2% 126
2015
Q1 		– Sell
-9,100
Closed -$121K – 274
2014
Q4 		$121K Buy
+9,100
New +$116K 0.01% 174

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

J. Goldman & Co's BSX Position: Q2 2026 in Review

J. Goldman & Co reduced its Boston Scientific (BSX) stake by 71% in Q2 2026, selling an estimated $1.71M and leaving 13,000 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #544.

J. Goldman & Co first reported a position in BSX in Q3 2013 and has held it in 13 quarters since. The position peaked at $16.3M in Q1 2019. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • J. Goldman & Co held 13,000 shares of Boston Scientific worth $555K as of Q2 2026.
  • J. Goldman & Co sold 31,485 Boston Scientific shares in Q2 2026, an estimated $1.71M.
  • Boston Scientific made up 0.01% of J. Goldman & Co's portfolio in Q2 2026, its #544 holding.
  • J. Goldman & Co first reported a position in Boston Scientific in Q3 2013 and has held it in 13 quarters since.
  • J. Goldman & Co's Boston Scientific position peaked at $16.3M in Q1 2019.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.